article thumbnail

UniQure offers a closer look at the leading hemophilia B gene therapy

Bio Pharma Dive

Doctors on Tuesday got a more detailed idea of how the therapy works and who might be eligible to take it, as results from a late-stage trial were presented at ASH.

article thumbnail

Bluebird executive joins Flagship startup Tessera as CMO

Bio Pharma Dive

David Davidson is leaving Bluebird bio after nearly a decade as the gene therapy developer's top doctor. His new home, Tessera, just raised $230 million to advance its "gene writing" research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details

Bio Pharma Dive

Uptake of Casgevy and Lyfgenia may be slow despite their dramatic benefit, physicians said, citing complexities in treatment, manufacturing and reimbursement.

article thumbnail

BioMarin's hemophilia gene therapy Roctavian lands FDA nod with 'glimmers' of enthusiasm among doctors

Fierce Pharma

After an initial rejection in 2020 and a review delay earlier this year, BioMarin’s Roctavian has finally got the FDA go-ahead to introduce a gene therapy for a not-so-rare disorder.

article thumbnail

New data underline cancer risk of Bluebird therapy for brain disease

Bio Pharma Dive

Seven young boys given Bluebird's Skysona later developed blood cancers, findings that could shape how doctors balance the gene therapy’s risks against its benefit.

article thumbnail

As Vertex and CRISPR build out Casgevy launch, doctor sees strong demand and warns of possible supply hitches

Fierce Pharma

As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their CRISPR-based gene-editing therapy Casgevy, one doctor who treats sickle cell disease patients is already | As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their world-first CRISPR-based gene therapy Casgevy, one doctor (..)

Doctors 99
article thumbnail

AI tool may help doctors select best drugs for COVID patients

pharmaphorum

It could also be made more powerful by incorporating personal genetic information and gene expression profiles in tissues such as the lungs, they suggest. The post AI tool may help doctors select best drugs for COVID patients appeared first on.

Doctors 135